monovalent degrader + full antagonist of ER_

orally efficacious in xenograft model

from ligand-based design of full antag.

ACS Med. Chem. Lett., May 29, 2020

Genentech, South San Francisco, CA

Structure of full antagonist and efficient degrader of ERα, GNE-149

GNE-149 is an efficient monovalent degrader and full antagonist of estrogen receptor alpha with significant oral bioavailability in higher species. The standard-of-care selective ER degrader (SERD) fulvestrant is not orally…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: